Acadia Healthcare (NASDAQ:ACHC) had its price objective raised by analysts at Raymond James from $65.00 to $70.00 in a report released on Monday, Price Targets.com reports. The brokerage presently has a “strong-buy” rating on the stock. Raymond James’ price objective would indicate a potential upside of 12.40% from the stock’s previous close.
ACHC has been the subject of a number of other research reports. Mizuho raised their price objective on shares of Acadia Healthcare from $53.00 to $62.00 and gave the company a “neutral” rating in a report on Friday, April 30th. Credit Suisse Group lifted their price target on shares of Acadia Healthcare from $54.00 to $56.00 and gave the stock a “neutral” rating in a report on Monday, March 8th. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating and set a $65.00 price objective for the company. in a report on Monday, April 19th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Acadia Healthcare from $55.00 to $62.00 and gave the stock a “hold” rating in a report on Monday, April 19th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $57.75.
Shares of ACHC opened at $62.28 on Monday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.26. Acadia Healthcare has a 52 week low of $23.01 and a 52 week high of $63.06. The stock has a market capitalization of $5.57 billion, a price-to-earnings ratio of 55.12, a PEG ratio of 1.49 and a beta of 1.49. The stock has a fifty day moving average of $59.32 and a 200-day moving average of $50.30.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, April 28th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. Acadia Healthcare had a return on equity of 7.55% and a net margin of 3.19%. As a group, equities analysts forecast that Acadia Healthcare will post 2.33 EPS for the current year.
In other news, Director Reeve B. Waud sold 109,443 shares of the firm’s stock in a transaction that occurred on Friday, March 12th. The shares were sold at an average price of $59.12, for a total transaction of $6,470,270.16. Following the completion of the sale, the director now owns 25,765 shares of the company’s stock, valued at approximately $1,523,226.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the company. CLARET ASSET MANAGEMENT Corp bought a new stake in Acadia Healthcare in the 1st quarter valued at about $205,000. Envestnet Asset Management Inc. increased its holdings in shares of Acadia Healthcare by 21.6% during the first quarter. Envestnet Asset Management Inc. now owns 111,555 shares of the company’s stock valued at $6,374,000 after acquiring an additional 19,809 shares in the last quarter. Symmetry Partners LLC acquired a new position in shares of Acadia Healthcare during the first quarter worth approximately $527,000. State of Michigan Retirement System lifted its holdings in shares of Acadia Healthcare by 1.9% in the 1st quarter. State of Michigan Retirement System now owns 32,981 shares of the company’s stock worth $1,885,000 after purchasing an additional 600 shares in the last quarter. Finally, Virginia Retirement Systems ET AL lifted its holdings in shares of Acadia Healthcare by 29.4% in the 1st quarter. Virginia Retirement Systems ET AL now owns 27,700 shares of the company’s stock worth $1,583,000 after purchasing an additional 6,300 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.
See Also: What is a stock buyback?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.